Migdal Insurance & Financial Holdings’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-170
Closed -$30K 551
2022
Q3
$30K Hold
170
﹤0.01% 362
2022
Q2
$34K Buy
170
+15
+10% +$3.2K ﹤0.01% 412
2022
Q1
$36K Sell
155
-100
-39% -$23.5K ﹤0.01% 470
2021
Q4
$69K Buy
255
+29
+13% +$7.18K ﹤0.01% 416
2021
Q3
$55K Sell
226
-67
-23% -$16.9K ﹤0.01% 435
2021
Q2
$70K Buy
293
+38
+15% +$8.66K ﹤0.01% 450
2021
Q1
$56K Buy
255
+47
+23% +$9.43K ﹤0.01% 536
2020
Q4
$36K Buy
+208
New +$35.9K ﹤0.01% 561
2020
Q3
Sell
-385
Closed -$55K 738
2020
Q2
$55K Buy
+385
New +$53.3K ﹤0.01% 515
2019
Q2
Sell
-1,589
Closed -$209K 747
2019
Q1
$209K Buy
+1,589
New +$196K 0.01% 401
2018
Q4
Sell
-1,609
Closed -$240K 768
2018
Q3
$240K Buy
1,609
+862
+115% +$131K 0.01% 494
2018
Q2
$115K Buy
747
+737
+7,370% +$111K ﹤0.01% 501
2018
Q1
$1K Buy
+10
New +$1.47K ﹤0.01% 663

Other funds holding LH

Migdal Insurance & Financial Holdings's LH Position: Q4 2022 in Review

Migdal Insurance & Financial Holdings sold out of Labcorp (LH) in Q4 2022, closing a stake of 170 shares — an estimated $30K sold.

Migdal Insurance & Financial Holdings first reported a position in LH in Q1 2018 and held it in 13 quarters. The position peaked at $240K in Q3 2018. 971 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 170 Labcorp shares in Q4 2022, an estimated $30K.
  • Migdal Insurance & Financial Holdings first reported a position in Labcorp in Q1 2018 and held it in 13 quarters.
  • Migdal Insurance & Financial Holdings's Labcorp position peaked at $240K in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2022, filed 23 Jan 2023.